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  16 
Abstract 17 
Increasing antibiotic resistance is making the identification of novel antimicrobial 18 
targets critical. Recently, we discovered an inhibitor of protein tyrosine phosphatase 19 
CpsB, fascioquinol E (FQE), which unexpectedly inhibited the growth of Gram-20 
positive pathogens. CpsB is a member of the polymerase and histidinol phosphate 21 
phosphatase (PHP) domain family. Another member of this family found in a variety 22 
of Gram-positive pathogens is DNA polymerase PolC. We purified the PHP domain 23 
from PolC (PolCPHP), and showed that this competes away FQE inhibition of CpsB 24 
phosphatase activity. Furthermore, we showed that this domain hydrolyses the 5'-p-25 
nitrophenyl ester of thymidine-5’-monophosphate (pNP-TMP), which has been used 26 
as a measure of exonuclease activity. Finally, we showed that FQE not only inhibits 27 
the phosphatase activity of CpsB, but also ability of PolCPHP to catalyse the hydrolysis 28 
of pNP-TMP. This suggests that PolC may be the essential target of FQE, and that the 29 
PHP domain may represent an as yet untapped target for the development of novel 30 
antibiotics.   31 
 32 
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The search for novel antimicrobials is of the utmost importance with ever-increasing 39 
rates of resistance to the current breed of antibiotics, along with the lack of drugs in 40 
the development pipeline. With the polysaccharide capsule the major virulence factor 41 
of Streptococcus pneumoniae, our work has concentrated on identifying inhibitors of 42 
capsule as a novel anti-virulence target by focusing on a phosphoregulatory system, 43 
highly conserved amongst all but two pneumococcal serotypes, as well as across 44 
bacterial species [1]. During a recent search for inhibitors of CpsB, a protein tyrosine 45 
phosphatase from S. pneumoniae, we discovered an inhibitor, Fascioquinol E (FQE), 46 
which inhibited CpsB both in vitro and in vivo [2]. Unexpectedly, FQE also inhibited 47 
the growth of a number of Gram-positive pathogens, including Streptococcus 48 
pneumoniae and Staphylococcus aureus, while not affecting Gram-negative bacteria 49 
[3]. This was surprising as the gene encoding for CpsB is not essential [4]. 50 
 51 
CpsB belongs to the polymerase and histidinol phosphatase (PHP) family of proteins 52 
(PFAM: PF02811) [4,5]. Over 95% of these proteins are found in prokaryotes and 53 
along with the protein tyrosine phosphatases involved in regulation of capsular 54 
polysaccharides, also include histidinol phosphate phosphatases from bacteria and 55 
yeasts, DNA polymerases from a range of Gram-positive and Gram-negative bacteria, 56 
as well as a number of as yet un-characterised proteins [5].  The presence of DNA 57 
polymerases piqued our interest; as such enzymes are essential and are thus critical 58 
for the ability of organisms to survive. 59 
 60 
Prokaryotic replicative polymerases belong to the C family of DNA polymerases and 61 
show little similarity with polymerases found in eukaryotes. For this reason, DNA 62 
polymerase have been the target for the development of antimicrobials, with these 63 
being primarily nucleotide analogues [6,7]. Low-GC bacteria, such as the 64 
pneumococcus, possess two DNA polymerases, DnaE and PolC [8]. Recently, the in 65 
vitro reconstitution of the Gram-positive replication machinery from Bacillus subtillus 66 
showed that PolC is responsible for rapid, processive chromosomal replication, while 67 
DnaE is responsible for the extension of RNA primers [9]. This differs from the 68 
protypical system in E. coli where both functions are maintained by the DnaE 69 
polymerase. 70 
 71 
While both PolC and DnaE possess a PHP domain, the PHP domain of PolC is 72 
bisected by an exonuclease domain (Figure 1A) [10,11]. A number of point mutations 73 
isolated in the PolC PHP domain in B. subtillis and S. aureus have illustrated that this 74 
domain is essential, and of importance for the exonuclease activity of the enzyme 75 
[10,12]. One such residue that has been mutated in S. aureus PolC (H339) is highly 76 
conserved throughout PHP domains, and additionally is important for CpsB 77 
phosphatase activity [2,13]. Interestingly, the PHP domains present in DnaE 78 
polymerases contain mutations in a number of conserved metal binding sites, 79 
questioning the importance of the domain in this polymerase [5]. Thus, we 80 
hypothesised that inhibition of the PHP domain from PolC may be responsible for the 81 
Gram-positive specific growth inhibition seen with FQE.  82 
 83 
In this study, we have investigated whether the PHP domain of PolC is a target for the 84 
development of antibiotics, using a previously characterised inhbitor of CpsB, FQE. 85 
We have shown that addition of purified PolCPHP can reverse the inhibition of CpsB 86 
phosphatase activity. Furthermore, we have developed a novel assay to screen for 87 
PolC inhibitors by showing that the enzyme catalyses the hydrolysis of 5'-p-88 
nitrophenyl ester of thymidine-5’-monophosphate (pNP-TMP), an activity associated 89 
with a variety of exonucleases. Using this assay, we have shown that PolC activity is 90 
inhibited by FQE, suggesting that the PHP domain may be a novel target for the 91 
development of antibiotics that target a broad range of PHP domain containing 92 
proteins.  93 
Materials and Methods 94 
Growth Media and Growth Conditions 95 
Escherichia coli strains were grown in Luria-Bertani broth (10 g/L Tryptone, 5 g/L 96 
yeast extract, 5 g/L NaCl) broth or agar, with transformation carried out using CaCl2-97 
treated cells. E. coli K12 strain DH5α was used for routine cloning, while strain M15 98 
(Qiagen) was used for induction of the 6xHis-PolCPHP protein. 99 
 100 
CpsB purification and phosphatase assay 101 
CpsB purification, as well as hydrolysis of p-nitrophenyl phosphate (pNPP) was 102 
undertaken as described previously [2].  103 
 104 
Computational analysis 105 
Protein structure comparison was undertaken using Phyre2 [14], with structures of 106 
CpsB from S. pneumoniae (PDBID: 2WJD) and PolC from Geobacillus kaustophilus 107 
(PDBID: 3F2B). Sequence analysis was undertaken using DNAMAN.  108 
 109 
Cloning and overproduction of PolC PHP. 110 
The PHP domain from D39 PolC (Gene ID as from KEGG database: SPD_0254) was 111 
amplified from S. pneumoniae D39 chromosomal DNA (AS65 112 
cgcGGATCCgttgagtttcatgctcatactaac and AS66 113 
tgcGGTACCttattaaataaccagtttacgagccagttc) (nt1017-2024). The PHP domain was 114 
identified by comparison with the known structure and sequence of Geobacillus 115 
kaustophilus (Gene ID as from KEGG database: GK1258)[11] and CpsB (Gene ID as 116 
from KEGG database: SPD_0316) [15] from S. pneumoniae. This DNA was 117 
subsequently cloned into the BamHI and HindIII sites of pQE30 and the construct 118 
confirmed by DNA sequencing. pQE30:PolCPHP was then transformed into M15. For 119 
induction, an overnight culture was subscultured 1/20 for 2 hrs (OD600 ≈ 0.4) at 120 
37°C, and then transferred to 20 °C where it was induced for 16 hrs with 1 mM IPTG. 121 
6 L were then pelleted (8000g for 20 min) and resuspended in phosphate buffer pH 122 
7.4, 500 mM NaCl and 20 mM imidazole. Bacteria were lysed in a Constant Systems 123 
Cell Disruptor constant pressure cell, and the soluble recombinant protein was 124 
purified using an AKTA prime plus (GE Life Sciences) with a HiTrap column as 125 
described by the manufacturer. Protein was eluted using gradient elution performed 126 
up to 500 mM imidazole. SDS-PAGE analysis was used to identify the fractions 127 
containing purified PolCPHP and then these were dialysed into 20mM Tris pH 8, with 128 
50% glycerol and subsequently stored at -20 °C in aliquots. Final concentration was 129 
0.04 mg/mL, with purity estimated at > 90%. Protein concentration was estimated by 130 
comparing to known concentration of BSA.  131 
 132 
pNP-TMP assay 133 
The hydrolysis of pNP-TMP by PolCPHP was investigated using assays as described 134 
previously [16]. Assays were routinely carried out in duplicate in 100 µl volumes in a 135 
96 well microtitre tray, with change in OD420 monitored every minute on a 136 
Powerwave XS (Biotek) at 25 °C. Assay buffer consisted of 50 mM Tris pH 8, 150 137 
mM NaCl and 1 mM DTT. pNP-TMP (Sigma, cat no. T4150) was diluted with assay 138 
buffer (50mM Tris pH 8, 150 mM NaCl), and stored in single use aliquots. Initial 139 
rates were estimated by reading A420 at t = 10 min versus t = 0 min. The rate of pNP-140 
TMP hydrolysis was calculated using a value of 12 950 M-1cm-1 for the e420 of p-141 
nitrophenyl at pH 8.0. 142 
 143 
The effect of enzyme concentration was measured using 2 to 32 nM of PolCPHP, using 144 
standard assay conditions, with [Mn2+] = 1mM. In order to estimate Michelis-Menten 145 
kinetic paramters, data was measured with pNP-TMP concentrations from 0.15 to 10 146 
mM where [Mn2+] = 1 mM. Km and Kcat were determined by non-linear regression 147 
using GraphPad Prism. The effect of metal ions on the rate of reaction was studied 148 
using [Mg2+] = 1 mM and [Mn2+] = 1 mM under standard assay conditions. The IC50 149 
of FQE was determined using [PolCPHP] = 12.5 nM, and [ρNP-TMP] = 2 mM. The 150 
data was analysed with GraphPad Prism using a non-linear fit of log10 [FQE] vs 151 
normalized response. Ki values were determined using the Cheng-Prusoff equation 152 
[17].  Data reported here are the means of three independent assays ± standard error of 153 
the mean. The mode of inhibition of FQE was investigated by varying the 154 
concentrations of FQE alongside varying the concentrations of pNP-TMP. The data 155 
was plotted as double reciprocal plots and assessed using Lineweaver-Burk analysis. 156 
 157 
Results 158 
Alignment of CpsB and PolC from S. pneumoniae 159 
The recent structure of Geobacillus kaustophilus PolC (PDB: 3F2B) has illustrated 160 
that it contains numerous domains, including a PHP domain which is bisected by the 161 
region necessary for the exonuclease activity of the protein (Figure 1A) [11].  As we 162 
postulated that an inhibitor of CpsB phosphatase activity may also inhibit the function 163 
of fellow PHP domain member PolC, we aligned published structures of the two 164 
proteins as well as their four conserved motifs as determined by Aravind & Koonin 165 
[5] (Figures 1B & 1C). While there is a published structure of CpsB from S. 166 
pneumoniae, we used the PolC structure from Geobacillus kaustophilus, which 167 
Phyre2 predictions mapped with 100% accuracy to S. pneumoniae PolC, as well as 168 
other Gram-positive PolC proteins, such as that from S. aureus [14]. Alignment of the 169 
protein structures of CpsB and PolC via RCSB showed that they are indeed highly 170 
similar (P-value of 1.37e-04 by jFATCAT_rigid algorithm) [18] (Figure 1B). 171 
Additionally, comparison of the protein sequence of the conserved motifs found that 172 
the PHP domains from PolC and CpsB share conservation at the majority of these 173 
sites (Figure 1C). Interestingly, one essential amino acid in S. aureus PolC (H339) 174 
[12] constitutes a hypothetical conserved metal binding site found across PHP 175 
domains, and indeed has been shown to be important for CpsB phosphatase activity 176 
[2,13]. This prompted us to investigate the possibility that CpsB phosphatase inhibitor 177 
FQE also inhibits the PolC activity. 178 
 179 
Cloning and purification of S. pneumoniae PolCPHP 180 
 181 
Initially, we attempted to clone and express full length S. pneumoniae PolC protein, 182 
however, while a clone was successfully produced, we were not able to induce 183 
expression in a range of E. coli strains (data not shown). As we were interested 184 
specifically in the PHP domain, we cloned and expressed the PHP domain from S. 185 
pneumoniae D39 PolC (aa 339-808) as a His6-tagged protein. While the majority of 186 
PolCPHP was insoluble after induction (approximately 90%), we were able to purify a 187 
significant quantity from the soluble fraction with > 90% purity as judged by 188 
Coomassie blue stained PAGE (Figure 2A).  189 
 190 
Purified His6-PolCPHP suppresses FQE inhibition of CpsB phosphatase activity 191 
We required an assay to test our hypothesis that FQE was able to inhibit PolCPHP 192 
function. Unlike CpsB, PolCPHP did not catalyse the hydrolysis of p-nitrophenyl 193 
phosphate (data not shown). Thus, we investigated whether adding increasing 194 
concentrations of PolCPHP into a CpsB phosphatase assay could decrease the efficacy 195 
of the inhibitor FQE. Increased levels of PolCPHP resulted in significantly increased 196 
CpsB phosphatase activity and counteracted the inhibitory effect of FQE (Figure 2B). 197 
This suggested that PolCPHP was able to bind or sequester FQE. Addition of BSA to 198 
the assay did not produce such effects (data not shown).  199 
 200 
Hydrolysis of ρNP-TMP by PolCPHP 201 
Having shown that PolCPHP was likely to bind FQE, we next developed an assay to 202 
directly test whether FQE can inhibit PolCPHP function. PolCPHP contains the PHP 203 
domain bisected by an additional domain important for the enzyme’s intrinsic 3’-5’ 204 
exonuclease activity (Figure 1A) [10]. While the PHP domain does not possess 205 
exonuclease activity itself [11], mutational alteration of various amino acids of the 206 
PHP domain do impact exonuclease as well as polymerase activity [10]. In recent 207 
times, the E. coli proof reading exonuclease (ε) subunit of the DNA polymerase 208 
machinery has been shown to hydrolyse the 5'-ρ-nitrophenyl ester of TMP (pNP-209 
TMP)[16]. pNP-TMP is a phosphodiester analog of a natural nucleic acid substrate. 210 
Numerous other exonucleases have also been shown to hydrolyse pNP-TMP [19]. 211 
Thus, we hypothesized that PolCPHP would hydrolyse pNP-TMP.  212 
 213 
Incubation of PolCPHP with pNP-TMP resulted in the release of p-nitrophenyl from 214 
pNP-TMP. Preliminary results showed that a pH of 8 was optimal (data not shown). 215 
Values of v0 were proportional to the concentration of PolCPHP over a 20 fold range 216 
(Figure 3A). Additionally, varying the substrate concentration illustrated the kinetics 217 
of the reaction fitted well with Michelis-Menten Kinetics. The kinetic parameters for 218 
the hydrolysis of pNP-TMP were as follows; Km = 1.9 ± 0.1 mM and Kcat = 13 ± 219 
0.22 s-1 (Figure 3B).  220 
 221 
As with other PHP proteins, as well as the other exonucleases investigated for the 222 
ability to hydrolyse pNP-TMP, there was a requirement for a metal ion in order for 223 
the reaction to proceed. Mn2+ was by far the preferred ion, with activity significantly 224 
higher than when Mg2+ was used (Figure 2C). This also correlates with the 225 
phosphatase activity of CpsB, with Mn2+ being the metal ion of preference for optimal 226 
phosphatase activity [15].  227 
 228 
FQE inhibits PolCPHP activity 229 
Having developed a suitable assay to measure PolCPHP activity, we investigated the 230 
ability of FQE to inhibit this activity. FQE was able to inhibit the ability of PolCPHP to 231 
catalyse the hydrolysis of pNP-TMP. FQE was confirmed to be a competitive 232 
inhibitor using Lineweaver-Burk analysis (Supplementary Figure 1).  Although it was 233 
unlikely that FQE was acting as a chelator as we used [Mn] = 1mM, varying [Mn] 234 
also did not effect inhibition, providing further evidence FQE was not a simple 235 
divalent metal chelator (data not shown). The inhibition constant (Ki) was calculated 236 
to be 2.1 ±0.04 µM for FQE inhibition of PolCPHP (Figure 4). This result provided 237 
direct evidence that the enzymatic activity of the PHP domain of PolC could be 238 
inhibited by FQE, suggesting that this may be the essential target of FQE in S. 239 






The polymerase and histidinol phosphate phosphatase domain was first described 246 
nearly 15 years ago [5], and since has been further characterised via the production of 247 
structures for a great number of its members [11,15,20] as well as functional analyses 248 
[4,13,15]. Its relative abundance in prokaryotes, along with its scarcity in eukaroytes 249 
suggests that is makes an attractive target for the development of a new breed of anti-250 
microbials that target a variety of proteins, resulting in broad range specificity. The 251 
discovery of novel targets for the development of antimicrobials is becoming 252 
increasingly desperate, with the advent of so called superbugs such as methicillin 253 
resistant S. aureus (MRSA) [21]. This study has shown that the PHP domain is a 254 
drugable target, for which one inhibitor may inhibit many critical functions of a 255 
bacterial pathogen, targeting both essential cellular processes as well as activities 256 
important for virulence.  257 
 258 
In a recent study describing a high throughput screen for inhibitors of protein tyrosine 259 
phosphatase CpsB from Streptococcus pneumoniae, we discovered an inhibitor, FQE, 260 
which resulted in in vitro inhibition of CpsB phosphatase activity, as well as 261 
subsequent reduction of capsular polysaccharide production in whole S. pneumoniae 262 
[2]. Interestingly, FQE also inhibited the growth of S. pneumoniae, as well as a 263 
number of other Gram-positive but not Gram-negative pathogens [3]. Thus, we were 264 
interested if FQE was also targeting an essential component of Gram-positive 265 
bacterium. As PolC, and in particular the PHP domain of PolC, is known to be 266 
essential, we hypothesised that this domain was another target of FQE. Indeed, the 267 
PHP domains from these proteins are highly similar, both structurally as well as 268 
through sequence conservation (Figure 1B & 1C).  While we were unsuccessful in 269 
purifying whole PolC from S. pneumoniae, we were able to purify sufficient 270 
quantities of a truncated form of PolC containing the PHP domain. While PolCPHP did 271 
not show any activity against pNPP, the addition of PolCPHP to FQE-CpsB 272 
phosphatase inhibitor assays significantly increased phosphatase activity (Figure 2B), 273 
suggesting PolCPHP was able to sequester FQE and decrease inhibition of CpsB. This 274 
provided the first evidence that FQE was able to bind the DNA polymerase PolC. 275 
 276 
In order to demonstrate the true effect of FQE on PolC, we required a functional 277 
assay. Hamdan et al. (2002) [16] have shown that the proof reading exonuclease (ε) 278 
subunit of Escherichia coli DNA polymerase III was able to hydrolyse pNP TMP. 279 
Indeed, oligoribonucleases from a number of species have also been shown to have 280 
such activity [19]. While traditional studies of exonuclease activity have involved the 281 
use of radiolabelled ssDNA or primer template substrates that have mismatched 282 
termini, this method provides a simple continuous method that can be monitored on a 283 
spectrophotometer. We found that PolCPHP was able to hydrolyse pNP TMP. The 284 
recorded Km of 1.94 was not dissimilar to that reported for other enzymes previously 285 
shown to hydrolyse pNP TMP [16,19]. There was also other similarities with these 286 
enzymes, with PolCPHP’s ability to hydrolyse pNP TMP showing an absolute 287 
dependence on the presence of a metal ion. While the addition of Mg2+ promoted 288 
some activity, the best ion by far was Mn2+, as for other assayed enzymes. 289 
Additionally, the optimum pH was pH 8. Interestingly, as well as showing similar 290 
characterisitics to other exonucleases assayed with this substrate, all these 291 
characteristics are the same as that seen for PHP domain family member CpsB, when 292 
we are assaying the PTP’s ability to catalyse the hydrolysis of pNPP. 293 
 294 
When we investigated if FQE inhibits the ability of PolCPHP to hydrolyse pNP TMP, 295 
we found that it did so with a similar IC50 to that of CpsB phosphatase activity. Ki for 296 
FQE (KiPolCPHP = 2.1 µM and KiCpsB = 4 µM) were also similar. This suggests that 297 
FQE is a general PHP domain inhibitor, as it is able to inhibit two different activities 298 
of two different enzymes at similar concentrations. Furthermore, this also provides 299 
further evidence that while the PHP domain of PolC is not sufficient for exonuclease 300 
activity [11], the PHP domain is essential, perhaps due to its ability to recruit metal 301 
ions required for exonuclease activity. Interestingly, the PHP domain of DnaE, 302 
another bacterial DNA polymerase present in Gram-positive and also Gram-negative 303 
pathogens, has been shown to possess exonuclease activity in thermophiles [22], 304 
while in E. coli the PHP domain has been shown to bind the ε subunit, which itself 305 
possess exonuclease activity [23]. Thus, it would be of interest to see if FQE would 306 
also inhibit the function of DnaE, both from Gram-positive and Gram-negative 307 
bacterial pathogens.  308 
 309 
The fact that FQE inhibits two different functions of two different PHP domain 310 
containing proteins, suggests that it is a general PHP domain inhibitor. Thus, it is 311 
interesting to consider other proteins FQE could potentially inhibit. These would 312 
include histidinol phosphate phosphatase (HPP). PHP domain containing Hpps are 313 
present in a number of bacteria [24] and also in yeast. In some bacteria, the histidine 314 
biosynthesis pathway has been shown to be a antibiotic target [25], while in yeast 315 
such Hpps have been postulated as ideal targets for the development of novel anti-316 
fungals [26]. Other possible targets include the family X DNA polymerases involved 317 
in DNA repair [27], the TatD proteins encoding a DNase [28], as well as proteins with 318 
as yet undefined roles such as YcdX [29]. We are currently investigating whether 319 
FQE can also inhibit the function of other PHP proteins. 320 
 321 
In a time of increasing antibiotic resistance, and few new drugs in development, the 322 
identification of a novel targets for the development of antimicrobial agents is critical. 323 
Furthermore, the identification of one which targets multiple proteins, is critical not 324 
only for increasing its spectrum of action, but also as a method of limiting the 325 
development of antibiotic resistance. The PHP domain, with its significant prevalence 326 
in bacteria but not eukaryotes, is one such target. 327 
 328 
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monophosphate ; pNPP, p-nitrophenyl phosphate;PTP, protein tyrosine phosphatase. 332 
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Figure Legends 337 
 338 
Figure 1. Alignment of CpsB and PolC. A. Cartoon schematic of PolC structure 339 
illustrating the PHP domain with the exonuclease domain present in the middle. B. 340 
Structure comparison between Cps4B (Pdb: 2WJE) (Black Shading) and PolC 341 
(Pdb:3F2b) (White shading) shows similar structures (Aligned using RCSB). B. 342 
Sequence conservation of conserved motifs of PHP between PolC (top) and CpsB 343 
(bottom) from S. pneumoniae with putative active site residues highlighted in inverse 344 
black (Generated using DNAMAN).  345 
 346 
Figure 2.  PolCPHP supresses FQE inhibition of CpsB phosphatase activity.A. 1 µg 347 
purified PolCPHP separated on 12 % SDS-PAGE and stained with Coomassie Blue 348 
shows > 90% purity. B. Increasing concentrations of PolCPHP (33 nM, 16.5 nM and 349 
8.25 nM) were added to CpsB phosphatase assay where CpsB concentration was 2.5 350 
nM. Addition of PolCPHP significantly increased the activity of CpsB phosphatase 351 
activity in the presence of inhibitor FQE (10 µM) (*** - P < 0.001; student’s t-tailed 352 
test). 353 
 354 
Figure 3. PolCPHP hydrolyses ρNP-TMP. A. The rate of hydrolysis of pNP-TMP as a 355 
function of PolCPHP concentration. The concentration of pNP-TMP was 2 mM and the 356 
concentration of MnCl2 was 1 mM. B. Varying concentration of pNP-TMP produces 357 
results that fit well with Michelis Menten kinetics. C. Rate of hydrolysis of pNP-TMP 358 
by PolCPHP with either 1mM MnCl2 or 1 mM MgCl2. Concentration of PolCPHP was 359 
12.5 nM and concentration of pNP-TMP was 2 mM .  360 
 361 
Figure 4. FQE inhibits PolCPHP hydrolysis of ρNP-TMP. PolCPHP hydrolysis of 362 
ρNP-TMP in the presence of FQE. IC50 of FQE was 4.2 µM. [Mn2+] was 1 mM and 363 
[pNP-TMP] was 2 mM. 364 
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